International Clinical Trial: Chaigui Jieyu Qufa Decoction for CRF in Driver Gene-negative Lung Adenocarcinoma Trial

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890051) titled 'Chaigui Jieyu Qufa Decoction for CRF in Driver Gene-negative Lung Adenocarcinoma Trial' on Oct. 16.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Condition: Lung Adenocarcinoma Cancer-related Fatigue Liver Depression and Spleen Deficiency Syndrome (Traditional Chinese Medicine)

Intervention: Other: Chai-Gui Jieyu Qufa Placebo Granules

Recruitment Status: Not recruiting

Ph...